Anzeige
Mehr »
Mittwoch, 05.11.2025 - Börsentäglich über 12.000 News
SuperBuzz explodiert um 20% nach Mega-Deal mit NASDAQ-Werberiesen!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A1JCLB | ISIN: FR0011049824 | Ticker-Symbol: 4ZG
Frankfurt
05.11.25 | 08:13
2,895 Euro
+2,66 % +0,075
Branche
Software
Aktienmarkt
Sonstige
1-Jahres-Chart
MEDIAN TECHNOLOGIES Chart 1 Jahr
5-Tage-Chart
MEDIAN TECHNOLOGIES 5-Tage-Chart
RealtimeGeldBriefZeit
2,8852,92015:14

Aktuelle News zur MEDIAN TECHNOLOGIES Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
MEDIAN TECHNOLOGIES Aktie jetzt für 0€ handeln
MoLion Point Capital founder joins Median Technologies board2
MoMedian Technologies Appoints Didric Cederholm to Its Board of Directors190Regulatory News: Median Technologies (FR0011049824, ALMDT, PEA-PME scheme eligible, "Median" or the "Company"), manufacturer of eyonis, a suite of artificial intelligence (AI) powered Software...
► Artikel lesen
28.10.Median Technologies: €19 Million EIB Financing Raised To Boost AI-Enabled Cancer Diagnosis Platform1
23.10.Median Technologies Reports First-Half 2025 Financial Results and Provides Key Q3 2025 Business Results284Operating loss reduced by €4 million in first six months of 2025 versus H1 2024, highlighting improved corporate efficiency H1 2025 revenues at €11.3 million, vs €10.9 million in H1 2024...
► Artikel lesen
21.10.Median Technologies Receives €19 Million From the European Investment Bank, Corresponding to the First Tranche Under the 2025 Loan Facility269Proceeds to support the commercial launch of eyonis®LCS in the U.S. and Europe, and accelerate the broader development of eyonis®, Median's AI-powered Software as a Medical Device suite for early...
► Artikel lesen
13.10.Median Technologies Announces the Availability of the Preparatory Documents for the Shareholders' Ordinary and Extraordinary General Meeting on October 31, 2025216Regulatory News: The shareholders of Median Technologies (FR0011049824, ALMDT, PEA/PME scheme eligible, "Median" or "The Company") are invited to participate in the Shareholders' Ordinary and Extraordinary...
► Artikel lesen
06.10.Median Technologies: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital as of September 30, 2025211Pursuant to article L-223-8 II of the French "code de Commerce" and 223-16 of the AMF's General Regulations. Regulatoy News: Median Technologies (Paris:ALMDT): Total number of shares...
► Artikel lesen
22.09.Median Technologies Business Update Following Successful Financing264Cash runway extended until at least Q4 2026 and potentially well beyond eyonis® LCS commercial launch preparations underway in the U.S. eyonis® LCS subject to advanced negotiations...
► Artikel lesen
08.09.Median Technologies: H2 2025 Financial Communication Calendar286Regulatory News: Median Technologies (FR0011049824, ALMDT, PEA-PME scheme eligible, "Median" or the "Company")manufacturer of eyonis, a suite of artificial intelligence (AI) powered Software as...
► Artikel lesen
04.09.Median Technologies: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital as of August 31, 2025261Pursuant to article L-223-8 II of the French "code de Commerce" and 223-16 of the AMF's General Regulations. Regulatory News: Median Technologies (Paris:ALMDT): Total number of shares...
► Artikel lesen
07.08.Median Technologies: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital as of July 31, 2025293Pursuant to article L-223-8 II of the French "code de Commerce" and 223-16 of the AMF's General Regulations. Regulatory News: Median Technologies (Paris:ALMDT): Total number of shares...
► Artikel lesen
01.08.Median Technologies Has Completed a Capital Increase of € 23.9 Million508Capital increase of 23.9 million euros from institutional and retail investors at a subscription price of €1.66 per ABSA Extension of the Company's cash runway until Q4 2026 Regulatory...
► Artikel lesen
23.07.Following the signature of a financial agreement for up to €37.5 million with the EIB, Median Technologies launches an approximately €22 million capital increase to support commercialization of eyonis LCS in the U.S. ...620Capital increase in the form of shares with attached warrants ("ABSA") without preferential subscription rights by way of an equity public offering and with a priority subscription period of 5...
► Artikel lesen
11.07.Median Technologies Signs Financial Agreement for up to €37.5 Million New Financing Facility With the European Investment Bank (EIB)532Regulatory News: Median Technologies FR0011049824, ALMDT, PEA-PME scheme eligible, "Median" or the "Company"), manufacturer of eyonis, a suite of artificial intelligence (AI) powered Software as...
► Artikel lesen
09.07.Median Technologies: Half Year Liquidity Contract Statement333Regulatory News: Under the liquidity contract entrusted by Median Technologies (PARIS: ALMDT, FR0011049824, ALMDT, PEA/SME eligible, "Median" or "the Company") to TP ICAP (Europe), the following...
► Artikel lesen
07.07.Median Technologies: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital as of June 30, 2025284Pursuant to article L-223-8 II of the French "code de Commerce" and 223-16 of the AMF's General Regulations. Regulatory News: Median Technologies (Paris:ALMDT): Total number of shares...
► Artikel lesen
01.07.Median Technologies Files European Application for Class IIb CE Marking of Its AI-Based Software as a Medical Device for Lung Cancer Screening, eyonis LCS360Class IIb CE marking is a prerequisite for Median's eyonis LCS Software as a Medical Device marketing in Europe Lung cancer screening programs are already implemented in several European...
► Artikel lesen
10.06.Median Technologies: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital as of May 31, 2025330Pursuant to article L-223-8 II of the French "code de Commerce" and 223-16 of the AMF's General Regulations. Regulatory News: Median Technologies (Paris:ALMDT): Total number of shares...
► Artikel lesen
28.05.Median Technologies announces the availability of the preparatory documents for the Shareholders' Ordinary and Extraordinary General Meeting on June 17, 2025410Regulatory News: The shareholders of Median Technologies (FR0011049824, ALMDT, PEA/PME scheme eligible, "Median" or "The Company") are invited to participate in the Shareholders' Ordinary and Extraordinary...
► Artikel lesen
27.05.Median Technologies to Showcase iCRO's Central and AI-Powered Imaging Services for Oncology Clinical Trials at ASCO 2025335Median is a leading provider of imaging services to the world's top oncology pharma companies ASCO abstracts position Median as highly differentiated provider of AI-imaging services for...
► Artikel lesen
Weiter >>
44 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1